Prevention and early detection of cervical cancer in Chile: An updated literature review
DOI:
https://doi.org/10.52611/confluencia.2026.1700Keywords:
National health programs, Program evaluation, Uterine cervical neoplasms, Papanicolaou test, Human Papillomavirus DNA testsAbstract
Introduction: Cervical cancer remains a global public health problem, despite being largely preventable. In Chile, mortality has decreased thanks to the Screening and Control Program implemented in 1987, but cervical cancer remains significant, ranking fourth in incidence and ninth in mortality, with notable gaps in Papanicolaou coverage. Objective: To compare cervical cancer prevention strategies in Chile with international recommendations, identifying gaps and opportunities for improvement to guide public health policies. Methodology: A literature review of national and international literature was conducted, including systematic reviews, meta-analyses, and articles in Spanish and English. From 311 initial documents, 21 studies were selected and analyzed regarding primary and secondary prevention, screening, and self-sampling. Result: The Papanicolaou test remains the main screening method in Chile, performed every three years for women aged 25 to 64, achieving only 66,2% coverage. The HPV test, more sensitive and cost-effective, is offered complementarily for women aged 30 to 64. HPV self-sampling has shown high acceptance, increasing participation and detecting precancerous lesions. Internationally, primary HPV screening allows greater detection and longer intervals between tests, whereas its implementation in Chile is limited. Discussion: There is a persistent lag in the adoption of cervical cancer prevention strategies. Low Papanicolaou test coverage and barriers to access highlight the need to modernize secondary prevention approaches. Conclusion: Despite progress, gaps in coverage and access persist. Expanding the use of HPV testing and self-sampling is recommended, as these are feasible, cost-effective strategies that optimize secondary prevention and promote greater equity in access.
References
World Health Organization. International Agency for Research on Cancer. Cervix Uteri. Cancer site ranking [Internet]. Ginebra: Global Cancer Observatory; 2025 [citado el 6 de octubre 2025]. Disponible en: https://gco.iarc.who.int/media/globocan/factsheets/cancers/23-cervix-uteri-fact-sheet.pdf
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin [Internet]. 2018 [citado el 6 de octubre 2025];68(6):394-424. Disponible en: https://doi.org/10.3322/caac.21492
Bruni L, Serrano B, Roura E, Alemany L, Cowan M, Herrero R, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health [Internet]. 2022 [citado el 6 de octubre 2025];10(8):e1115-e1127. Disponible en: https://doi.org/10.1016/s2214-109x(22)00241-8
Ministerio de Salud de Chile. Guías clínicas AUGE Cáncer Cérvico Uterino (GPC-CaCU) [Internet]. Santiago: MINSAL; 2015 [citado el 6 de octubre 2025]. Disponible en: https://diprece.minsal.cl/wrdprss_minsal/wp-content/uploads/2016/03/GPC-CaCU-Final.PLdocx.pdf
Institute for Health Metrics and Evaluation. GBD Results [Internet]. USA: University of Washington; 2025 [citado el 6 de octubre 2025]. Disponible en: https://vizhub.healthdata.org/gbd-results/
Centro de Políticas Públicas e Innovación en Salud (CIPS), Facultad de Gobierno, Universidad del Desarrollo. Resultados CASEN 2022 Papanicolaou [Internet]. Santiago: UDD; 2023 [citado el 6 de octubre 2025]. Disponible en: https://gobierno.udd.cl/cips/files/2023/08/resultadoscasenpap.pdf
National Cancer Institute. Cervical Cancer Screening [Internet]. USA: NIH; 2024 [citado el 6 de octubre 2025]. Disponible en: https://www.cancer.gov/types/cervical/screening#_3
Godoy LR, Possati-Resende JC, Guimarães YM, Pedrão PG, Dos Reis R, Longatto-Filho A. Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better? Cancers (Basel) [Internet]. 2022 [citado el 6 de octubre 2025];14(11):2612. Disponible en: https://doi.org/10.3390/cancers14112612
Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, et al. The IARC Perspective on Cervical Cancer Screening. N Engl J Med [Internet]. 2021 [citado el 6 de octubre 2025];385(20):1908-18. Disponible en: https://doi.org/10.1056/NEJMsr2030640
Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med [Internet]. 2007 [citado el 6 de octubre 2025];357(16):1579-88. Disponible en: https://doi.org/10.1056/NEJMoa071430
Terrazas S, Ibáñez C, Lagos M, Poggi H, Brañes J, Barriga MI, et al. Examen de detección de virus papiloma humano en el tamizaje de cáncer cervicouterino en un Servicio de Salud de Santiago, Chile. Rev Med Chil [Internet]. 2015 [citado el 6 de octubre 2025];143(3):408. Disponible en: https://doi.org/10.4067/s0034-98872015000100007
Ferreccio C. Nuevas estrategias de prevención y control de cáncer de cuello uterino en Chile. Salud Pública Méx [Internet]. 2018 [citado el 6 de octubre 2025];60(6):713-21. Disponible en: https://doi.org/10.21149/8577
Kyrgiou M, Arbyn M, Bergeron C, Bosch FX, Dillner J, Jit M, et al. Cervical screening: ESGO–EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC). Br J Cancer [Internet]. 2020 [citado el 6 de octubre 2025];123(4):510-7. Disponible en: https://doi.org/10.1038/s41416-020-0920-9
Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol [Internet]. 2008 [citado el 6 de octubre 2025];111(1):167-77. Disponible en: https://doi.org/10.1097/01.aog.0000296488.85807.b3
Nishio H, Iwata T, Nomura H, Morisada T, Takeshima N, Takano H, et al. Liquid-based cytology vs conventional cytology for detection of uterine cervical lesions: a prospective observational study. Jpn J Clin Oncol [Internet]. 2018 [citado el 6 de octubre 2025];48(6):522-8. Disponible en: https://doi.org/10.1093/jjco/hyy050
Sefuthi T, Nkonki L. A systematic review of economic evaluations of cervical cancer screening methods. Syst Rev [Internet]. 2022 [citado el 6 de octubre 2025];11(1):162. Disponible en: https://doi.org/10.1186/s13643-022-02017-z
Malone C, Barnabas RV, Buist DSM, Tiro JA, Winer RL. Cost-effectiveness studies of HPV self-sampling: a systematic review. Prev Med [Internet]. 2020 [citado el 6 de octubre 2025];132:105953. Disponible en: https://doi.org/10.1016/j.ypmed.2019.105953
Di Gennaro G, Licata F, Trovato A, Bianco A. Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies and randomized clinical trials. Front Public Health [Internet]. 2022 [citado el 6 de octubre 2025];10:1003461. Disponible en: https://doi.org/10.3389/fpubh.2022.1003461
Vega-Crespo B, Neira VA, Maldonado-Rengel R, López D, Delgado-López D, Guerra Astudillo G, Verhoeven V. Barriers and Advantages of Self?Sampling Tests, for HPV Diagnosis: A Qualitative Field Experience Before Implementation in a Rural Community in Ecuador. Int J Women Health [Internet]. 2024 [citado el 6 de octubre 2025];16:947-60. Disponible en: https://doi.org/10.2147/ijwh.s455118
Cora-Cruz MS, Martinez O, Perez S, Fang CY. Evaluating human papillomavirus (HPV) self-sampling among Latinas in the United States: A systematic review. Cancer Med [Internet]. 2024 [citado el 6 de octubre 2025];13(16):e70098. Disponible en: https://doi.org/10.1002/cam4.70098
Ministerio de Salud de Argentina, Instituto Nacional del Cáncer. Manual para la implementación del test de VPH en contexto programático [Internet]. Argentina: INC; 2016 [citado el 6 de octubre 2025]. Disponible en: https://www.fasgo.org.ar/images/manual-para-la-implementacion-test-vph-en-contexto-programatico.pdf
Porras C, Hildesheim A, González P, Schiffman M, Rodríguez AC, Wacholder S, et al. Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing. J Natl Cancer Inst [Internet]. 2014 [citado el 6 de octubre 2025];107(1):400. Disponible en: https://doi.org/10.1093/jnci/dju400
Costa S, Verberckmoes B, Castle PE, Arbyn M. Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening. Br J Cancer [Internet]. 2023 [citado el 6 de octubre 2025];128(5):805-13. Disponible en: https://doi.org/10.1038/s41416-022-02094-w
Serrano B, Ibáñez R, Robles C, Peremiquel-Trillas P, de Sanjosé S, Bruni L. Worldwide use of HPV self-sampling for cervical cancer screening. Prev Med [Internet]. 2022 [citado el 6 de octubre 2025];154:10690. Disponible en: https://doi.org/10.1016/j.ypmed.2021.106900
Nothacker J, Nury E, Roebl Mathieu M, Raatz H, Meerpohl JJ, Schmucker C. Women's attitudes towards a human papillomavirus-based cervical cancer screening strategy: a systematic review. BMJ Sex Reprod Health [Internet]. 2022 [citado el 6 de octubre 2025];48(4):295-306. Disponible en: https://doi.org/10.1136/bmjsrh-2022-201515 /
Chepkorir J, Guillaume D, Lee J, Duroseau B, Xia Z, Wyche S, et al. The Role of Health Information Sources on Cervical Cancer Literacy, Knowledge, Attitudes and Screening Practices in Sub-Saharan African Women: A Systematic Review. Int J Environ Res Public Health [Internet]. 2024 [citado el 6 de octubre 2025];21(7):872. Disponible en: https://doi.org/10.3390/ijerph21070872
Srinath A, van Merode F, Rao SV, Pavlova M. Barriers to cervical cancer and breast cancer screening uptake in low- and middle-income countries: a systematic review. Health Policy Plan [Internet]. 2023 [citado el 6 de octubre 2025];38(4):509-27. Disponible en: https://doi.org/10.1093/heapol/czac104
Mantula F, Toefy Y, Sewram V. Barriers to cervical cancer screening in Africa: a systematic review. BMC Public Health [Internet]. 2024 [citado el 6 de octubre 2025];24(1):525. Disponible en: https://doi.org/10.1186/s12889-024-17842-1
Petersen Z, Jaca A, Ginindza TG, Maseko G, Takatshana S, Ndlovu P, et al. Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review. BMC Womens Health [Internet]. 2022 [citado el 6 de octubre 2025];22(1):486. Disponible en: https://doi.org/10.1186/s12905-022-02043-y
Mon HM, Robb KA, Demou E. Effectiveness of workplace cancer screening interventions: a systematic review. BMC Cancer [Internet]. 2024 [citado el 6 de octubre 2025];24(1):999. Disponible en: https://doi.org/10.1186/s12885-024-12649-0
Ssentongo P, McCall-Hosenfeld JS, Calo WA, Moss J, Lengerich EJ, Chinchilli VM, Ba DM. Association of human papillomavirus vaccination with cervical cancer screening: A systematic review and meta-analysis. Medicine (Baltimore) [Internet]. 2022 [citado el 6 de octubre 2025];101(28):e29329. Disponible en: https://doi.org/10.1097/md.0000000000029329
Kassie AM, Abate BB, Kassaw MW, Aragie TG, Geleta BA, Shiferaw WS. Impact of knowledge and attitude on the utilization rate of cervical cancer screening tests among Ethiopian women: A systematic review and meta-analysis. [Internet]. 2020 [citado el 6 de octubre 2025];15(12):e0239927. Disponible en: https://doi.org/10.1371/journal.pone.0239927
Zhang M, Sit JWH, Chan DNS, Akingbade O, Chan CWH. Educational Interventions to Promote Cervical Cancer Screening among Rural Populations: A Systematic Review. Int J Environ Res Public Health [Internet]. 2022 [citado el 6 de octubre 2025];19(11):6874. Disponible en: https://doi.org/10.3390/ijerph19116874
Romli R, Abd Rahman R, Chew KT, Mohd Hashim S, Mohamad EMW, Mohammed Nawi A. Empirical investigation of e-health intervention in cervical cancer screening: A systematic literature review. PLoS One [Internet]. 2022 [citado el 6 de octubre 2025];17(8):e0273375. Disponible en: https://doi.org/10.1371/journal.pone.0273375
Centro de Políticas Públicas e Innovación en Salud. Falta de tiempo, desconocimiento y olvido son las razones principales de por qué las mujeres no se realizan el examen papanicolaou en Chile [Internet]. Santiago: UDD; 2023 [citado el 6 de octubre 2025]. Disponible en: https://gobierno.udd.cl/cips/2023/08/01/falta-de-tiempo-desconocimiento-y-olvido-son-las-razones-principales-de-por-que-las-mujeres-no-se-realizan-el-examen-papanicolaou-en-chile/
Fundación Arturo López Pérez. Programa “Hazte un tiempo, comienza por ti” atendió a más de 14 mil mujeres en su primer año [Internet]. Santiago: FALP; 2024 [citado el 6 de octubre 2025]. Disponible en: https://www.falp.org/noticia/programa-hazte-un-tiempo-comienza-por-ti-atendio-a-mas-de-14-mil-mujeres-en-su-primer-ano/
Léniz J, Barriga MI, Lagos M, Ibáñez C, Puschel K, Ferreccio C. Autotoma vaginal para detección de virus del papiloma humano en mujeres no adherentes a tamizaje con Papanicolaou en Chile. Salud Publica Mex [Internet]. 2013 [citado el 6 de octubre 2025];55(2):162-9. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342013000200007&lng=es
Additional Files
Published
Issue
Section
License
Copyright (c) 2026 Revista Confluencia

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.



